Capital Planning Advisors’s Health Catalyst HCAT Stock Holding History

Capital Planning Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,870	Closed	-$144K	–	126
2022 Q3	$144K	Sell	14,870 -629	-4%	-$8.33K	0.04%	120
2022 Q2	$225K	Buy	15,499 +629	+4%	+$10.7K	0.06%	119
2022 Q1	$389K	Hold	14,870	–	–	0.08%	116
2021 Q4	$589K	Hold	14,870	–	–	0.11%	105
2021 Q3	$744K	Hold	14,870	–	–	0.15%	92
2021 Q2	$825K	Hold	14,870	–	–	0.17%	89
2021 Q1	$695K	Hold	14,870	–	–	0.16%	90
2020 Q4	$647K	Buy	+14,870	New	+$549K	0.16%	89

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Planning Advisors's HCAT Position: Q4 2022 in Review

Capital Planning Advisors sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 14,870 shares — an estimated $144K sold.

Capital Planning Advisors first reported a position in HCAT in Q4 2020 and held it in 8 quarters. The position peaked at $825K in Q2 2021. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

Capital Planning Advisors reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
Capital Planning Advisors sold 14,870 Health Catalyst shares in Q4 2022, an estimated $144K.
Capital Planning Advisors first reported a position in Health Catalyst in Q4 2020 and held it in 8 quarters.
Capital Planning Advisors's Health Catalyst position peaked at $825K in Q2 2021.
166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on Capital Planning Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.